Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I

Pagani, O.O.PaganiSessa, C.C.SessaNolè, F.F.NolèCrivellari, D.D.CrivellariLombardi, D.D.LombardiThürlimann, B.B.ThürlimannHess, D.D.HessBorner, MarkusMarkusBornerBauer, J.J.BauerMartinelli, G.G.MartinelliGraffeo, R.R.GraffeoZucchetti, M.M.ZucchettiD'Incalci, M.M.D'IncalciGoldhirsch, A.A.Goldhirsch2024-10-252024-10-252000https://boris-portal.unibe.ch/handle/20.500.12422/160871en600 - Technology::610 - Medicine & healthEpidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II studyarticle10.7892/boris.11506610.1023/A:1008392927656